Impact of 18F-FDG-PET/CT in detection of the primary site and change management in patients with metastases of unknown primary.

Abstract

During the follow-up period of the 71 patients, 12 patients achieved complete response, 12 patients showed partial response and 25 patients had stable disease. Conclusion: 18 F-FDG PET/CT is additive imaging modality that help in early detection of the primary malignant site in patients with MUO and so enabling selection of suitable management protocols that might improve patients' outcome.